Literature DB >> 11144253

Production of terbium-152 by heavy ion reactions and proton induced spallation.

B J Allen1, G Goozee, S Sarkar, G Beyer, C Morel, A P Byrne.   

Abstract

Terbium-152 (Tb-152) is of potential value as a radiotracer for radiolanthanides in positron emission tomography. We report the production of Tb-152 by heavy ion reactions at the ANU Tandem accelerator, and by the spallation method at the CERN proton accelerator using the on-line ISOLDE separator, obtaining microcurie and millicurie yields, respectively. After purification, a phantom image in PET is obtained which shows the feasibility of using Tb-152 for monitoring the kinetics of Tb-149 and other radiolanthanides. However, the current availability of this radioisotope will be restricted to major nuclear physics research centres.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11144253     DOI: 10.1016/s0969-8043(00)00164-0

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  10 in total

Review 1.  Cutting edge rare earth radiometals: prospects for cancer theranostics.

Authors:  Alexander W E Sadler; Leena Hogan; Benjamin Fraser; Louis M Rendina
Journal:  EJNMMI Radiopharm Chem       Date:  2022-08-26

Review 2.  Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.

Authors:  Lukas M Carter; Sophie Poty; Sai Kiran Sharma; Jason S Lewis
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-30       Impact factor: 1.921

3.  Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations.

Authors:  Charlotte Duchemin; Thomas E Cocolios; Kristof Dockx; Gregory J Farooq-Smith; Olaf Felden; Roberto Formento-Cavaier; Ralf Gebel; Ulli Köster; Bernd Neumaier; Bernhard Scholten; Ingo Spahn; Stefan Spellerberg; Maria E Stamati; Simon Stegemann; Hannelore Verhoeven
Journal:  Front Med (Lausanne)       Date:  2021-05-12

4.  Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations.

Authors:  Zeynep Talip; Francesca Borgna; Cristina Müller; Jiri Ulrich; Charlotte Duchemin; Joao P Ramos; Thierry Stora; Ulli Köster; Youcef Nedjadi; Vadim Gadelshin; Valentin N Fedosseev; Frederic Juget; Claude Bailat; Adelheid Fankhauser; Shane G Wilkins; Laura Lambert; Bruce Marsh; Dmitry Fedorov; Eric Chevallay; Pascal Fernier; Roger Schibli; Nicholas P van der Meulen
Journal:  Front Med (Lausanne)       Date:  2021-04-22

5.  Folate receptor targeted alpha-therapy using terbium-149.

Authors:  Cristina Müller; Josefine Reber; Stephanie Haller; Holger Dorrer; Ulli Köster; Karl Johnston; Konstantin Zhernosekov; Andreas Türler; Roger Schibli
Journal:  Pharmaceuticals (Basel)       Date:  2014-03-13

Review 6.  Systemic targeted alpha radiotherapy for cancer.

Authors:  Bj Allen
Journal:  J Biomed Phys Eng       Date:  2013-09-17

7.  Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging.

Authors:  Cristina Müller; Christiaan Vermeulen; Karl Johnston; Ulli Köster; Raffaella Schmid; Andreas Türler; Nicholas P van der Meulen
Journal:  EJNMMI Res       Date:  2016-04-23       Impact factor: 3.138

8.  Folate-based radiotracers for PET imaging--update and perspectives.

Authors:  Cristina Müller
Journal:  Molecules       Date:  2013-04-29       Impact factor: 4.411

9.  Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice.

Authors:  Francesco Cicone; Silvano Gnesin; Thibaut Denoël; Thierry Stora; Nicholas P van der Meulen; Cristina Müller; Christiaan Vermeulen; Martina Benešová; Ulli Köster; Karl Johnston; Ernesto Amato; Lucrezia Auditore; George Coukos; Michael Stabin; Niklaus Schaefer; David Viertl; John O Prior
Journal:  EJNMMI Res       Date:  2019-06-11       Impact factor: 3.138

10.  Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN.

Authors:  Ben Webster; Peter Ivanov; Ben Russell; Sean Collins; Thierry Stora; Joao Pedro Ramos; Ulli Köster; Andrew Paul Robinson; David Read
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.